Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Gene expressions in Compound-treated vs. non-treated fibroblast of Leigh syndrome by DNA microarray analysis

ABSTRACT: Gene expressions in Compound-treated vs. non-treated fibroblast of Leigh syndrome by DNA microarray analysis

PROVIDER: PRJNA494635 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

Gene expressions in Compound-treated vs. non-treated fibroblast of Leigh syndrome by DNA microarray analysis

Project description:To overview compound-responsive genes in fibroblast, we performed microarray analysis of ~63,000 genes in compound-treated fibroblast of LSND3

2018-10-05 | GSE120817 | GEO

Compound PIP-RBPJ-1 treated human neural stem cells

Project description:Compound PIP-RBPJ-1 treated human neural stem cells

| PRJNA432342 | ENA

Nascent proteome analysis of proliferating and senescent BJ fibroblast treated with GC7

Project description:Analysis of proteomic changes in proliferating and senescent BJ fibroblast treated with eIF5A hypusination inhibitor GC7 for 12h.

2024-07-12 | PXD034334 | Pride

M.tuberculosis H37Rv: Control vs. anti-TB compound treated

Project description:To monitor the anti-tuberculosis compound IMB-YH-8 induced gene response profile at an early stage, we treated logarithmically growing M. tuberculosis with IMB-YH-8 at the concentration of 2.5 μg/ml throughout the first 4 hr.

2016-12-06 | GSE90858 | GEO

The analysis of transcriptional profiles of cybrid cells harbouring two pathogenic mtDNA variants associated with Leigh syndrome

Project description:The analysis of transcriptional profiles of cybrid cells harbouring two pathogenic mtDNA variants associated with Leigh syndrome i.e., m.9185T>C in the mt-ATP6 gene and m.13513G>A in the mt-ND5 gene, in comparison to cybrid cells harbouring control mtDNA haplogroups or the wt m.13513G variant.

2023-04-01 | E-MTAB-11035 | biostudies-arrayexpress

RNAseq of intracellular Toxoplasma gondii treated with Tartrolon E

Project description:Tartrolon E is a pan anti-apicomplexan compound derived from a symbiotic bacteria of shipworms. The mechanism of action of the compound is unknown, and attempts to select parasite mutants resistant to the compound has been unsuccessful. In this study, RNAseq was performed on human foreskin fibroblast cells (HFF) infected with Toxoplasma gondii RH strain and treated with Tartrolon E to identify genes targeted by the compound.

2019-11-12 | GSE140197 | GEO

RNA sequencing data of Mycobacterium marinum treated with compound 8

Project description:RNA sequencing data of Mycobacterium marinum treated with compound 8

| PRJNA933127 | ENA

Transcriptomic profiling of normal human cardiac fibroblast treated with halofuginone

Project description:Normal human cardiac fibroblast were treated with 200 nM halofuginone for 24 hours and the transcriptomic profile was measured by RNAseq.

2017-03-03 | GSE95059 | GEO

High-throughput sequencing of OS cells treated with activated compound B5.

Project description:High-throughput sequencing of OS cells treated with activated compound B5.

| PRJNA658912 | ENA

RNA-seq of human fibroblast cell cultures treated with resveratrol against DMSO treated controls, with and without siRNA treatment targeting SIRT1

Project description:Resveratrol (RSV) is a small compound with many reported beneficial effects, including increased expression of genes involved in inborn errors of metabolism. We wanted to investigate the effects of RSV on gene regulation on a global scale in order to detect new target genes for RSV mediated up-regulation with respect to disease treatment. Because fibroblasts are widely used diagnostically and reflect many metabolically important tissues well, we chose to investigate normal fibroblasts treated with RSV. We performed this with and without knock down of sirtuin 1 (SIRT1) since SIRT1 has been reported as a key mediator of RSV effects. We performed Next Generation Sequencing of RNA on 2 normal fibroblast cell line with and without the respective treatments.

2018-11-12 | E-MTAB-7360 | biostudies-arrayexpress

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data